Your browser doesn't support javascript.
loading
An in vitro study of dual drug combinations of anti-viral agents, antibiotics, and/or hydroxychloroquine against the SARS-CoV-2 virus isolated from hospitalized patients in Surabaya, Indonesia.
Miatmoko, Andang; Hendrianto, Eryk; Karsari, Deya; Dinaryanti, Aristika; Ertanti, Nora; Ihsan, Igo Syaiful; Purnama, Disca Sandyakala; Asmarawati, Tri Pudy; Marfiani, Erika; Rosyid, Alfian Nur; Wulaningrum, Prastuti Asta; Setiawan, Herley Windo; Siswanto, Imam; Tri Puspaningsih, Ni Nyoman.
Affiliation
  • Purwati; Stem Cell Research and Development Center, Institute of Tropical Disease, Universitas Airlangga, Mulyorejo, Surabaya, Indonesia.
  • Miatmoko A; Faculty of Vocations, Universitas Airlangga, Gubeng, Surabaya, Indonesia.
  • Nasronudin; Department of Biotechnology, Asia University, Wufeng, Taichung, Taiwan.
  • Hendrianto E; Stem Cell Research and Development Center, Institute of Tropical Disease, Universitas Airlangga, Mulyorejo, Surabaya, Indonesia.
  • Karsari D; Faculty of Pharmacy, Universitas Airlangga, Mulyorejo, Surabaya, Indonesia.
  • Dinaryanti A; Rumah Sakit Umum dan Rumah Sakit Khusus Infeksi, Universitas Airlangga, Mulyorejo, Surabaya, Indonesia.
  • Ertanti N; Stem Cell Research and Development Center, Institute of Tropical Disease, Universitas Airlangga, Mulyorejo, Surabaya, Indonesia.
  • Ihsan IS; Stem Cell Research and Development Center, Institute of Tropical Disease, Universitas Airlangga, Mulyorejo, Surabaya, Indonesia.
  • Purnama DS; Stem Cell Research and Development Center, Institute of Tropical Disease, Universitas Airlangga, Mulyorejo, Surabaya, Indonesia.
  • Asmarawati TP; Stem Cell Research and Development Center, Institute of Tropical Disease, Universitas Airlangga, Mulyorejo, Surabaya, Indonesia.
  • Marfiani E; Stem Cell Research and Development Center, Institute of Tropical Disease, Universitas Airlangga, Mulyorejo, Surabaya, Indonesia.
  • Yulistiani; Stem Cell Research and Development Center, Institute of Tropical Disease, Universitas Airlangga, Mulyorejo, Surabaya, Indonesia.
  • Rosyid AN; Rumah Sakit Umum dan Rumah Sakit Khusus Infeksi, Universitas Airlangga, Mulyorejo, Surabaya, Indonesia.
  • Wulaningrum PA; Rumah Sakit Umum dan Rumah Sakit Khusus Infeksi, Universitas Airlangga, Mulyorejo, Surabaya, Indonesia.
  • Setiawan HW; Faculty of Pharmacy, Universitas Airlangga, Mulyorejo, Surabaya, Indonesia.
  • Siswanto I; Rumah Sakit Umum dan Rumah Sakit Khusus Infeksi, Universitas Airlangga, Mulyorejo, Surabaya, Indonesia.
  • Tri Puspaningsih NN; Rumah Sakit Umum dan Rumah Sakit Khusus Infeksi, Universitas Airlangga, Mulyorejo, Surabaya, Indonesia.
PLoS One ; 16(6): e0252302, 2021.
Article in En | MEDLINE | ID: mdl-34143818
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / SARS-CoV-2 / COVID-19 Drug Treatment / Hydroxychloroquine / Anti-Bacterial Agents Limits: Animals / Humans Country/Region as subject: Asia Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / SARS-CoV-2 / COVID-19 Drug Treatment / Hydroxychloroquine / Anti-Bacterial Agents Limits: Animals / Humans Country/Region as subject: Asia Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2021 Document type: Article Affiliation country: Country of publication: